Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Hadar, Tuvia
Sidi, Jack
Rahima, Menashe
Rakowsky, Erika
Kahan, Ernesto
Sarov, Batya
and
Sarov, Israel
1986.
Significance of Specific Epstein‐Barr Virus IgA and Elevated IgG Antibodies to Viral Capsid Antigens in Nasopharyngeal Carcinoma Patients.
Journal of Medical Virology,
Vol. 20,
Issue. 4,
p.
329.
De‐Vathaire, F.
Sancho‐Garner, H.
De‐Thé, H.
Pieddeloup, C.
Schwaab, G.
Ho, J. H. C.
Ellouz, R.
Micheau, C.
Cammoun, M.
Cachin, Y.
and
De‐Thé, G.
1988.
Prognostic value of ebv markers in the clinical management of nasopharyngeal carcinoma (NPC): A multicenter follow‐up study.
International Journal of Cancer,
Vol. 42,
Issue. 2,
p.
176.
Lai, Kar Neng
Ho, Stephen
Leung, Joseph C. K.
and
Tsao, Shiu Ying
1991.
Soluble interleukin-2 receptors in patients with nasopharyngeal carcinoma.
Cancer,
Vol. 67,
Issue. 8,
p.
2180.
Sham, Jonathan S. T.
Choy, D.
Wei, W. I.
and
Yau, C. C.
1992.
Value of clinical follow‐up for local nasopharyngeal carcinoma relapse.
Head & Neck,
Vol. 14,
Issue. 3,
p.
208.
Wyatt, D.E.
Brooker, D.S.
Connolly, J.H.
and
Coyle, P.V.
1993.
Prognostic value of Epstein-Barr virus serology in patients with nasopharyngeal carcinoma.
Journal of Infection,
Vol. 26,
Issue. 2,
p.
171.
Yip, Timothy T. C.
Ngan, Roger K. C.
Lau, W. H.
Poon, Y. F.
Joab, Irene
Cochet, Chantal
and
Cheng, K. P.
1994.
A possible prognostic role of immunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA in patients with nasopharyngeal carcinoma.
Cancer,
Vol. 74,
Issue. 9,
p.
2414.
Ho, S.
Leung, S.F.
Leung, W.T.
Tsao, S.Y.
Kwan, W.H.
Choi, P.
and
Johnson, P.J.
1996.
Strong association between hyperferritinaemia and metastatic disease in nasopharyngeal carcinoma.
European Journal of Cancer Part B: Oral Oncology,
Vol. 32,
Issue. 4,
p.
242.
Hwang, Yue‐Ting
Chen, Pei‐Jer
Kao, Jia‐Horng
Wang, Tzung‐Dau
Wang, Hsih‐Hsi
Chu, Jan‐Show
Su, Ih‐Jen
and
Chen, Ding‐Shinn
1996.
Rapid hepatic failure associated with a contracted liver mimicking cirrhosis in a case of nasopharyngeal carcinoma with liver metastasis.
Liver,
Vol. 16,
Issue. 4,
p.
283.
Hwang, Jing-Min
Fu, Karen K
and
Phillips, Theodore L
1998.
Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
International Journal of Radiation Oncology*Biology*Physics,
Vol. 41,
Issue. 5,
p.
1099.
Noël, G.
Dessard-Diana, B.
Vignot, S.
and
Mazeron, J.J.
2002.
Les traitements des cancers du nasopharynx : revue de la littérature.
Cancer/Radiothérapie,
Vol. 6,
Issue. 2,
p.
59.
Chien, Yin-Chu
and
Chen, Chien-Jen
2003.
Epidemiology and Etiology of Nasopharyngeal Carcinoma: Gene-Environment Interaction.
Cancer Reviews: Asia-Pacific,
Vol. 01,
Issue. 01,
p.
1.
Karray, H.
Ayadi, W.
Fki, L.
Hammami, A.
Daoud, J.
Drira, M.M.
Frikha, M.
Jlidi, R.
and
Middeldorp, J.M.
2005.
Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
Journal of Medical Virology,
Vol. 75,
Issue. 4,
p.
593.
Lee, Nancy
Colevas, A. Dimitrios
and
Fu, Karen K.
2010.
Leibel and Phillips Textbook of Radiation Oncology.
p.
523.
Chen, Hao
Luo, Yao-Ling
Zhang, Lin
Tian, Li-Zhen
Feng, Zhi-Ting
and
Liu, Wan-Li
2013.
EA-D p45-IgG as a Potential Biomarker for Nasopharyngeal Carcinoma Diagnosis.
Asian Pacific Journal of Cancer Prevention,
Vol. 14,
Issue. 12,
p.
7433.
Chiu, Shih-Hsin
Wu, Chung-Chun
Fang, Chih-Yeu
Yu, Shu-Ling
Hsu, Hui-Yu
Chow, Yen-Hung
and
Chen, Jen-Yang
2014.
Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.
Oncotarget,
Vol. 5,
Issue. 18,
p.
8583.
Kang, Hyunseok
Kiess, Ana
and
Chung, Christine H.
2015.
Emerging biomarkers in head and neck cancer in the era of genomics.
Nature Reviews Clinical Oncology,
Vol. 12,
Issue. 1,
p.
11.
Chen, Hao
Zhong, Qiaohua
Wu, Xiaobin
Ding, Yanling
Chen, Qi
Xue, Ning
Xu, Yiwei
and
Chen, Shulin
2020.
Preliminary evaluation of a candidate international reference for Epstein–Barr virus capsid antigen immunoglobulin A in China.
Infectious Agents and Cancer,
Vol. 15,
Issue. 1,